WallStSmart

BeiGene, Ltd. (ONC)vsWestinghouse Air Brake Technologies Corp (WAB)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Westinghouse Air Brake Technologies Corp generates 115% more annual revenue ($11.51B vs $5.34B). WAB leads profitability with a 10.5% profit margin vs 5.4%. WAB trades at a lower P/E of 37.6x. WAB earns a higher WallStSmart Score of 64/100 (C+).

ONC

Hold

42

out of 100

Grade: D

Growth: 8.0Profit: 5.0Value: 5.7Quality: 6.5
Piotroski: 5/9Altman Z: 0.26

WAB

Buy

64

out of 100

Grade: C+

Growth: 6.7Profit: 6.5Value: 6.0Quality: 5.0
Piotroski: 2/9Altman Z: 1.68
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

ONCUndervalued (+79.5%)

Margin of Safety

+79.5%

Fair Value

$1717.18

Current Price

$317.00

$1400.18 discount

UndervaluedFair: $1717.18Overvalued
WABUndervalued (+16.1%)

Margin of Safety

+16.1%

Fair Value

$303.40

Current Price

$265.71

$37.69 discount

UndervaluedFair: $303.40Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

ONC2 strengths · Avg: 9.5/10
Revenue GrowthGrowth
32.8%10/10

Revenue surging 32.8% year-over-year

Debt/EquityHealth
0.259/10

Conservative balance sheet, low leverage

WAB0 strengths · Avg: 0/10

No standout strengths identified

Areas to Watch

ONC4 concerns · Avg: 3.5/10
Price/BookValuation
8.1x4/10

Trading at 8.1x book value

EPS GrowthGrowth
0.0%4/10

0.0% earnings growth

Return on EquityProfitability
7.5%3/10

ROE of 7.5% — below average capital efficiency

Profit MarginProfitability
5.4%3/10

5.4% margin — thin

WAB3 concerns · Avg: 3.7/10
P/E RatioValuation
37.6x4/10

Premium valuation, high expectations priced in

Altman Z-ScoreHealth
1.684/10

Distress zone — elevated risk

Piotroski F-ScoreQuality
2/93/10

Weak financial health signals

Comparative Analysis Report

WallStSmart Research

Bull Case : ONC

The strongest argument for ONC centers on Revenue Growth, Debt/Equity. Revenue growth of 32.8% demonstrates continued momentum.

Bull Case : WAB

Revenue growth of 13.0% demonstrates continued momentum. PEG of 1.37 suggests the stock is reasonably priced for its growth.

Bear Case : ONC

The primary concerns for ONC are Price/Book, EPS Growth, Return on Equity. A P/E of 120.4x leaves little room for execution misses.

Bear Case : WAB

The primary concerns for WAB are P/E Ratio, Altman Z-Score, Piotroski F-Score.

Key Dynamics to Monitor

ONC profiles as a hypergrowth stock while WAB is a value play — different risk/reward profiles.

WAB carries more volatility with a beta of 0.97 — expect wider price swings.

ONC is growing revenue faster at 32.8% — sustainability is the question.

ONC generates stronger free cash flow (161M), providing more financial flexibility.

Bottom Line

WAB scores higher overall (64/100 vs 42/100) and 13.0% revenue growth. ONC offers better value entry with a 79.5% margin of safety. Both earn "Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

BeiGene, Ltd.

HEALTHCARE · BIOTECHNOLOGY · USA

BeiGene, Ltd., an oncology company, engages in discovering and developing various treatments for cancer patients in the United States, China, Europe, and internationally. The company is headquartered in Camana Bay, the Cayman Islands.

Visit Website →

Westinghouse Air Brake Technologies Corp

INDUSTRIALS · RAILROADS · USA

Wabtec Corporation (derived from Westinghouse Air Brake Technologies Corporation) is an American company formed by the merger of the Westinghouse Air Brake Company (WABCO) and MotivePower Industries Corporation in 1999. It is headquartered in Pittsburgh, Pennsylvania.

Visit Website →

Want to dig deeper into these stocks?